ATE197903T1 - Peptid-kohlenwasserstoff konjugate, welche t-zell immunität bewirken - Google Patents
Peptid-kohlenwasserstoff konjugate, welche t-zell immunität bewirkenInfo
- Publication number
- ATE197903T1 ATE197903T1 AT93912042T AT93912042T ATE197903T1 AT E197903 T1 ATE197903 T1 AT E197903T1 AT 93912042 T AT93912042 T AT 93912042T AT 93912042 T AT93912042 T AT 93912042T AT E197903 T1 ATE197903 T1 AT E197903T1
- Authority
- AT
- Austria
- Prior art keywords
- carbohydrate
- peptide
- cell immunity
- effect
- immunogenic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/18—Acyclic radicals, substituted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/605—MHC molecules or ligands thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9201338A SE9201338D0 (sv) | 1992-04-28 | 1992-04-28 | New active compounds |
SE9202553A SE9202553D0 (sv) | 1992-09-07 | 1992-09-07 | New active compounds ii |
SE9203897A SE9203897D0 (sv) | 1992-12-23 | 1992-12-23 | New active compounds iii |
SE9301141A SE9301141D0 (sv) | 1993-04-06 | 1993-04-06 | New active compounds iv |
PCT/SE1993/000353 WO1993021948A1 (en) | 1992-04-28 | 1993-04-23 | Peptide-carbohydrate conjugates generating t-cell immunity |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE197903T1 true ATE197903T1 (de) | 2000-12-15 |
Family
ID=27484749
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT93912042T ATE197903T1 (de) | 1992-04-28 | 1993-04-23 | Peptid-kohlenwasserstoff konjugate, welche t-zell immunität bewirken |
Country Status (19)
Country | Link |
---|---|
US (2) | US5807559A (de) |
EP (1) | EP0675733B1 (de) |
JP (1) | JPH07506358A (de) |
CN (1) | CN1096032A (de) |
AT (1) | ATE197903T1 (de) |
AU (1) | AU676679B2 (de) |
CA (1) | CA2134097A1 (de) |
DE (1) | DE69329735T2 (de) |
DK (1) | DK0675733T3 (de) |
ES (1) | ES2155070T3 (de) |
GR (1) | GR3035501T3 (de) |
IL (1) | IL105503A (de) |
IS (1) | IS4010A (de) |
MA (1) | MA22885A1 (de) |
MY (1) | MY108864A (de) |
PT (1) | PT675733E (de) |
SI (1) | SI9300223A (de) |
TN (1) | TNSN93045A1 (de) |
WO (1) | WO1993021948A1 (de) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6083929A (en) * | 1991-05-06 | 2000-07-04 | The Biomembrane Institute | Extended type 1 chain glycosphingolipids as tumor-associated antigens |
DE4436164A1 (de) * | 1994-10-10 | 1996-04-11 | Hoechst Ag | Neue Kohlenhydratkonjugate als Inhibitoren der Zelladhäsion |
US6548643B1 (en) | 1994-11-16 | 2003-04-15 | Austin Research Institute | Antigen carbohydrate compounds and their use in immunotherapy |
US6841543B1 (en) * | 1996-01-31 | 2005-01-11 | President And Fellows Of Harvard College | Methods of inhibiting production of T helper type 2 cytokines in human immune cells |
US6218363B1 (en) * | 1996-08-28 | 2001-04-17 | Thomas Jefferson University | MHC peptides and methods of use |
WO1998015286A1 (en) * | 1996-10-08 | 1998-04-16 | La Jolla Institute For Allergy & Immunology | Carbohydrate-specific cytolytic t cells |
ES2265162T3 (es) * | 1997-03-27 | 2007-02-01 | Institut Pasteur | Carbohidrato glucopeptido de antigeno multiple, vacuna que comprende el mismo y su utilizacion. |
US20070237785A1 (en) * | 1997-03-27 | 2007-10-11 | Institut Pasteur | Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof |
US7550146B2 (en) * | 1997-04-16 | 2009-06-23 | Sloan-Kettering Institute For Cancer Research | Glycopeptide conjugates and uses thereof |
JP4308918B2 (ja) | 1997-04-16 | 2009-08-05 | スローン−ケッタリング インスティトゥート フォア キャンサー リサーチ | (2,6)−STエピトープクラスターを有するα−O−結合複合糖質、その製造方法および使用 |
AUPO732997A0 (en) * | 1997-06-12 | 1997-07-03 | Csl Limited | Ganglioside immunostimulating complexes and uses thereof |
EP1091751A4 (de) * | 1998-03-25 | 2005-01-19 | Sloan Kettering Institutefor C | Trimere antigene o-verbundene glykopeptidkonjugate und methoden zu deren präparation und verwendung |
JP2002509716A (ja) | 1998-03-31 | 2002-04-02 | ユニバーシティ テクノロジー コーポレイション | テロメラーゼ抗原に対する免疫応答を惹起するための方法および組成物 |
US7402307B2 (en) | 1998-03-31 | 2008-07-22 | Geron Corporation | Method for identifying and killing cancer cells |
US6573245B1 (en) * | 1998-04-28 | 2003-06-03 | Galenica Pharmaceuticals, Inc. | Modified polysaccharide adjuvant-protein antigen conjugates, the preparation thereof and the use thereof |
US20030091546A1 (en) * | 1998-11-12 | 2003-05-15 | Barber Jack R. | Methods of suppressing immune response by gene therapy |
US7854934B2 (en) * | 1999-08-20 | 2010-12-21 | Sloan-Kettering Institute For Cancer Research | Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof |
JP5111705B2 (ja) | 1999-08-20 | 2013-01-09 | スローン−ケッタリング インスティトュート フォア キャンサー リサーチ | 新規な複合多糖、グリコアミノ酸、これらへの中間体、及びこれらの使用 |
US7824687B2 (en) | 1999-08-20 | 2010-11-02 | Sloan-Kettering Institute For Cancer Research | Clustered multi-antigenic carbohydrate constructs, methods for their preparation, and uses thereof |
DE10005275A1 (de) * | 2000-02-07 | 2001-08-09 | Bayer Ag | Neuartige Glycokonjugate |
US20030049253A1 (en) * | 2001-08-08 | 2003-03-13 | Li Frank Q. | Polymeric conjugates for delivery of MHC-recognized epitopes via peptide vaccines |
UA79952C2 (en) * | 2001-12-10 | 2007-08-10 | Kabulesh Mafatlal Khamar | MYCOBACTERIUM w APPLICATIONS FOR CANCER TREATMENT |
JP2007516157A (ja) * | 2003-02-06 | 2007-06-21 | トリペップ アクチ ボラゲット | グリコシル化された抗原/抗体又はリガンド/受容体特異性交換体 |
WO2005077411A2 (en) * | 2004-02-10 | 2005-08-25 | Innate Pharma | Composition and method for the treatment of carcinoma |
WO2006121803A1 (en) | 2005-05-05 | 2006-11-16 | Sensient Flavors Inc. | Production of beta-glucans and mannans |
US8334257B2 (en) | 2005-12-20 | 2012-12-18 | Duke University | Methods and compositions for delivering active agents with enhanced pharmacological properties |
JP5792630B2 (ja) | 2009-01-28 | 2015-10-14 | エピミューン,インコーポレイティド | Pan−dr結合ポリペプチドおよびその使用 |
CN103038343A (zh) | 2010-03-23 | 2013-04-10 | 英特瑞克斯顿股份有限公司 | 条件表达治疗蛋白的载体,包含所述载体的宿主细胞,及其应用 |
EP2500033A1 (de) | 2011-03-17 | 2012-09-19 | Institut Pasteur | Verfahren zur Herstellung mehrfacher Antigen-Glycopeptid-Kohlenhydratkonjugate |
CA2837214C (en) | 2011-06-28 | 2021-06-01 | Inovio Pharmaceuticals, Inc. | A minimally invasive dermal electroporation device |
EP2606897A1 (de) | 2011-12-22 | 2013-06-26 | Laboratorios Del. Dr. Esteve, S.A. | Verfahren und Zusammensetzungen für die Behandlung von Krankheiten, die von eingehüllten Viren verursacht werden |
JP7210534B2 (ja) | 2017-07-12 | 2023-01-23 | ザ・ボード・オブ・トラスティーズ・オブ・ザ・リーランド・スタンフォード・ジュニア・ユニバーシティ | H3k27m変異を有するがんの処置のための組成物および方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2004744B (en) * | 1977-09-28 | 1982-05-26 | Sanderson A R | Immonulogical preparations |
CA1335883C (en) * | 1986-07-08 | 1995-06-13 | Bryan Michael Longenecker | Enhancement of the cellular immune response |
AU634153B2 (en) * | 1988-02-01 | 1993-02-18 | Wyeth Holdings Corporation | T-cell epitope as carriers molecule for conjugate vaccines |
AU4030989A (en) * | 1988-02-12 | 1989-09-06 | Regents Of The University Of California, The | Use of synthetic peptides to generate and manipulate cellular immunity |
US5229289A (en) * | 1988-03-11 | 1993-07-20 | The Biomembrane Institute | Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with animal and human and with synthetic carbohydrate-carrier conjugates |
CA1337403C (en) * | 1988-03-28 | 1995-10-24 | Biomembrane Institute (The) | Methods for the production of antibodies and induction of immune responses to tumor-associated gangliosides by immunization with ganglioside lactones |
EP0482068A1 (de) * | 1989-07-14 | 1992-04-29 | American Cyanamid Company | Cytokin- und hormonträger zur verwendung bei konjugatimpfstoffen |
AU6272190A (en) * | 1989-08-28 | 1991-04-08 | Pierce Chemical Company | Cationized carriers for immunogen production |
GB8924438D0 (en) * | 1989-10-31 | 1989-12-20 | Hoffmann La Roche | Vaccine composition |
IT1237764B (it) * | 1989-11-10 | 1993-06-17 | Eniricerche Spa | Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici. |
-
1993
- 1993-04-22 IL IL10550393A patent/IL105503A/en not_active IP Right Cessation
- 1993-04-23 DK DK93912042T patent/DK0675733T3/da active
- 1993-04-23 JP JP5519172A patent/JPH07506358A/ja not_active Abandoned
- 1993-04-23 DE DE69329735T patent/DE69329735T2/de not_active Expired - Fee Related
- 1993-04-23 AT AT93912042T patent/ATE197903T1/de not_active IP Right Cessation
- 1993-04-23 AU AU42746/93A patent/AU676679B2/en not_active Ceased
- 1993-04-23 WO PCT/SE1993/000353 patent/WO1993021948A1/en active IP Right Grant
- 1993-04-23 CA CA002134097A patent/CA2134097A1/en not_active Abandoned
- 1993-04-23 PT PT93912042T patent/PT675733E/pt unknown
- 1993-04-23 EP EP93912042A patent/EP0675733B1/de not_active Expired - Lifetime
- 1993-04-23 ES ES93912042T patent/ES2155070T3/es not_active Expired - Lifetime
- 1993-04-27 MA MA23178A patent/MA22885A1/fr unknown
- 1993-04-27 US US08/054,860 patent/US5807559A/en not_active Expired - Fee Related
- 1993-04-27 IS IS4010A patent/IS4010A/is unknown
- 1993-04-28 MY MYPI93000788A patent/MY108864A/en unknown
- 1993-04-28 CN CN93106340A patent/CN1096032A/zh active Pending
- 1993-04-28 SI SI9300223A patent/SI9300223A/sl unknown
- 1993-04-28 TN TNTNSN93045A patent/TNSN93045A1/fr unknown
-
1995
- 1995-05-16 US US08/442,378 patent/US6033669A/en not_active Expired - Fee Related
-
2001
- 2001-03-05 GR GR20010400341T patent/GR3035501T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
PT675733E (pt) | 2001-05-31 |
EP0675733A1 (de) | 1995-10-11 |
IL105503A0 (en) | 1993-08-18 |
AU676679B2 (en) | 1997-03-20 |
DK0675733T3 (da) | 2001-05-07 |
MA22885A1 (fr) | 1993-12-31 |
CN1096032A (zh) | 1994-12-07 |
DE69329735T2 (de) | 2001-08-02 |
JPH07506358A (ja) | 1995-07-13 |
TNSN93045A1 (fr) | 1994-03-17 |
DE69329735D1 (de) | 2001-01-11 |
CA2134097A1 (en) | 1993-11-11 |
SI9300223A (en) | 1994-03-31 |
WO1993021948A1 (en) | 1993-11-11 |
GR3035501T3 (en) | 2001-06-29 |
AU4274693A (en) | 1993-11-29 |
IS4010A (is) | 1993-10-29 |
EP0675733B1 (de) | 2000-12-06 |
US5807559A (en) | 1998-09-15 |
ES2155070T3 (es) | 2001-05-01 |
US6033669A (en) | 2000-03-07 |
MY108864A (en) | 1996-11-30 |
IL105503A (en) | 1999-05-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE197903T1 (de) | Peptid-kohlenwasserstoff konjugate, welche t-zell immunität bewirken | |
DK1036058T3 (da) | Adamantanderivater | |
DK1036059T3 (da) | Adamantanderivater | |
ATE296105T1 (de) | Iminbildende polysaccharide, deren herstellung und verwendung als zusatzmittel und immunstimulierende mittel | |
DE68906366T2 (de) | CD4-Polypeptidderivate. | |
FI953442A0 (fi) | Gonadotropiinia sisältäviä pakastekuivattuja pallosia | |
ES2056215T3 (es) | Composiciones de detergente. | |
DE69826684D1 (de) | Kovalent gebundenes n,o-carboxymethylchitosan und seine verwendungen | |
CO4930281A1 (es) | Conjugados utiles en el tratamiento del cancer de prostata | |
TR199501654A3 (de) | ||
IT8920898A0 (it) | Uso di sucralfato gel umido per il trattamento di ulcere del derma e come veicolo di farmaci ad attivita' topica. | |
DK0952853T3 (da) | Konjugat omfattende et aktivt middel, et polypeptid og en polyether | |
AR016427A1 (es) | CONJUGADOS uTILES PARA EL TRATAMIENTO DE CÁNCER DE PRoSTATA, Y UNA COMPOSICIoN FARMACÉUTICA QUE LOS COMPRENDE. | |
HU9203649D0 (en) | Method for producing inclusion compounds of nimesulide with cyclodextrines and pharmaceutical preparatives containing these compounds | |
DK0822808T3 (da) | Kompositmateriale med natriumstivelsesglycolat som bærermateriale og produkter deraf | |
JO1766B1 (en) | Effective new compounds | |
TW332816B (en) | Peptide and carbohydrate | |
NO961204L (no) | Triaryletylenderivater for anvendelse innen terapi | |
ATE211489T1 (de) | Chitosan enthaltende zusammensetzung | |
IT8820245A0 (it) | Palmitoil_fruttosio_1,6_difosfato, suo uso terapeutico e relativi metodi di preparazione. | |
FR2652266B1 (fr) | Vaccin protecteur contre l'hemophilose porcine. | |
TH13666A (th) | สารประกอบออกฤทธิ์ชนิดใหม่ | |
NO884941D0 (no) | Konjugat av metallothionein eller et metallothioneinfragment og et maalsoekende biologisk aktivt molekyl, som er anvendelig som mellomprodukt ved fremstilling av lignende merkede konjugater. | |
JP2002512261A5 (de) | ||
IT1229566B (it) | Gel di antracicline e loro uso terapeutico. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
EEIH | Change in the person of patent owner | ||
REN | Ceased due to non-payment of the annual fee |